XENICOS

Startup

XENICOS

Description

Xenicos develops biotechnology products and services designed for developing innovative immunotherapies, based on conjugated antibodies, designed to quickly and safely reset the immune system in patients with a severe immune disease or post-transplantation rejection.

XENICOS

Address

Netherlands

Contact

info@xenikos.com

Description

Xenicos develops biotechnology products and services designed for developing innovative immunotherapies, based on conjugated antibodies, designed to quickly and safely reset the immune system in patients with a severe immune disease or post-transplantation rejection.

Matchmaking

Connect with XENICOS

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

TRL